Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
Published Date: 02 Mar 2023
Researchers seek to predict markers of the state of obesity, the risk of associated complications and the response to diet or bariatric surgery.
Read Full NewsParticipation in accountable care organizations shows better diabetes care outcomes for patients in rural areas than for those in urban settings.
In patients with classical 21-hydroxylase deficiency, growth-promoting therapies have variable effects: They increase final height relative to midparental height in boys but not in girls.
Higher relative fat mass is associated with increased odds of having chronic diarrhea, although the measure alone shows limited ability to predict risk.
Risk rises with all three types of diabetes mellitus but mostly with type 2.
As GLP-1 use rise, constipation remains a leading cause of discontinuation. Experts offer practical strategies for prevention and management.
In patients with type 2 diabetes, 12 months of dapagliflozin therapy is significantly associated with reduced liver fat, independent of weight loss or other metabolic benefits.
Physicians must deploy specific tools in specific ways at specific times — adding to the time-consuming treatment costs.
1.
Housing aid linked to lower medical financial hardship among US renters with cancer
2.
Review looks at potential treatment targets in the tumor microenvironment.
3.
Low-Dose Radiation Provides Almost Perfect Control Over Slow-Growing Lymphoma.
4.
Lower Prostate Cancer Mortality Linked to Unavailable Clinical Trials.
5.
Research indicates that extended PSMA therapy is safe and effective for patients with prostate cancer.
1.
Understanding Hidrocystoma: Symptoms, Causes, and Treatment Options
2.
All You Need To Know About Cancer Antigen 27-29: Causes, Symptoms & Treatment
3.
Breaking Down Leukocytoclastic Vasculitis: Causes, Symptoms and Treatment
4.
Understanding Sickle Cell Anemia: Causes, Symptoms, and Treatment Options
5.
Clinical Analysis of Prostate Cancer
1.
International Lung Cancer Congress®
2.
Future NRG Oncology Meeting
3.
Genito-Urinary Oncology Summit 2026
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part V
2.
Pazopanib: A Game-Changer in Managing Advanced Renal Cell Carcinoma
3.
An Eagles View - Evidence-based discussion on Iron Deficiency Anemia- Important Points to Know
4.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part II
5.
A Continuation to The Evolving Landscape of First-Line Treatment for Urothelial Carcinoma
Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
© Copyright 2025 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
To get started please enter your email ID
Join to enhance your clinical skills and gain specialized in-depth medical knowledge